Tag: drug companies
November 25, 2018
What is In-licensing?
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
February 8, 2018
How Are Pharma Stocks Affected by Opioid Lawsuits?
Since the news about the lawsuits starting in 2016, Insys share price has dropped 65.56 percent from $28.63 to $9.62,...
December 25, 2017
Pharmaceutical Outlook 2018: M&A Deals Could Increase Drug Development
The Investing News Network takes a look at what could be the landscape for the pharma industry and its investors...
April 3, 2017
Mylan Expands its EpiPen Recall
More than 81,000 Mylan EpiPen devices have been recalled by the company resulting from a failure to activate auto-injection.
March 7, 2017
Trump Tweets, Pharma Stocks Tumble
President Donald Trump's tweet send pharma stocks down after promising he would bring drug prices down.
March 2, 2017
The Potential of Transdermal Drug Delivery
Drugs with low oral bioavailability risk failure in clinical trial: minimal absorption, after all, can translate to reduced efficacy. As...
January 16, 2017